The Trump Administration’s Drug Pricing Plan: Three Wishes For Consumers
This week President Trump will unveil his plan to help bring down the cost of prescription drugs, helping fulfill his...
CASE Op-ed: Tax Reform Isn’t the Only Way to Pad Our Pockets — So Would Nixing Durbin Provision
November 10, 2017 – https://bit.ly/2CkAQq3 As tax reform looms, by far the largest catchphrase in Washington is “put more money...
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/